The information contained on this website, and provided by Eczema Society of Canada/ Société canadienne de l’eczéma (ESC), ESC employees, or ESC volunteers reflects the current standards of eczema management in Canada, and should in no way dictate an exclusive treatment course. You should always seek diagnosis, treatment, and advice from a qualified physician.

Medicine is a constantly changing science and not all therapies are clearly established. New research changes drug and treatment therapies daily. The authors, editors, and publisher of this website have used their best efforts to provide information that is up-to-date and accurate and is generally accepted within medical standards at the time of publication. We do not warrant that the information contained within this website or any communications are accurate or complete. The reader should confirm the information on this website from other sources prior to use.


Clicking the consent agreement on our forms is considered consent for Eczema Society of Canada /La Société canadienne de l’eczéma (ESC) to send a variety of communications, including electronic communications which may include (i) newsletters, updates, and related publications (ii) announcements, and (iii) event, seminar, and fundraiser invitations. ESC may also communicate by postal mail on occasion.
Individuals may withdraw consent or unsubscribe at anytime by contacting ESC by email: [email protected] , by calling 1-855-329-3621, or by mail at 411 The Queenwsay South, PO Box 25009, Keswick, ON, L4P 4C2.


In furthering our mission, we have established a patient empowerment program where products are reviewed to earn recognition from the Eczema Society as an accepted choice for people with sensitive skin. People with sensitive skin and/or eczema may still find they do not tolerate certain products or certain ingredients. ESC recommends patch testing any product on a small area of skin, before applying it to a large area of skin, or your entire body. Speak with your own doctor about skin care products, and a skin care regimen that is specific to your condition.


Eczema Society of Canada (ESC) is a registered Canadian charity dedicated to improving the lives of Canadians living with eczema, by providing support, education, raising awareness, and supporting ongoing research activities. ESC does not provide specific medical advice and recommends patients consult a qualified physician for diagnosis, treatment, and ongoing consultation.

Part of ESC’s mandate is to inform Canadians of clinical research trials. This information on clinical research trials here in Canada may be of interest to you, either for general information on the state of eczema research in Canada, or for potential participation. ESC neither conducts clinical trials, nor recruits participants for clinical trials.

Clinical trials in Canada are conducted in accordance with Health Canada regulations. Study protocols are not monitored or reviewed by ESC. Although identifying clinical research trials in eczema is part of our services, this should not be construed as an endorsement of specific trials. Therefore, ESC cannot be held responsible for any events or incidents that may occur in connection with ESC publishing and/or notifying the public of available studies.

Questions related to studies should be addressed directly to the study sponsor. ESC may be reimbursed by study sponsors for costs incurred related to notifying subscribers and the general population about clinical trial availability in Canada.

ESC adheres strictly to our privacy policy, and does not release your contact information to any outside individuals, companies, charities, or organizations. Your privacy and confidentiality are important to us.


Any information collected by Eczema Society of Canada/ Société canadienne de l’eczéma (ESC) is used by the Society and will never be sold to or shared with outside parties. Your privacy and confidentiality are important to us. We may contact you with information related to eczema events in your local area, with our newsletters, or with information about new eczema treatments.